Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5277870
Max Phase: Preclinical
Molecular Formula: C85H115N17O25S2
Molecular Weight: 1839.08
Associated Items:
ID: ALA5277870
Max Phase: Preclinical
Molecular Formula: C85H115N17O25S2
Molecular Weight: 1839.08
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)CCNC(=S)Nc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(N)=O)[C@@H](C)O)C(C)C
Standard InChI: InChI=1S/C85H115N17O25S2/c1-9-43(6)70(100-79(120)59(39-67(111)112)97-80(121)60(40-103)91-65(108)26-29-89-85(128)90-46-20-23-49(52(34-46)84(125)126)68-50-24-21-47(105)35-62(50)127-63-36-48(106)22-25-51(63)68)82(123)93-54(27-31-129-8)74(115)96-58(38-66(109)110)76(117)94-56(33-45-16-11-10-12-17-45)77(118)99-69(42(4)5)81(122)98-55(32-41(2)3)75(116)92-53(18-13-14-28-86)73(114)95-57(37-64(87)107)78(119)101-71(44(7)104)83(124)102-30-15-19-61(102)72(88)113/h10-12,16-17,20-25,34-36,41-44,53-61,69-71,103-105H,9,13-15,18-19,26-33,37-40,86H2,1-8H3,(H2,87,107)(H2,88,113)(H,91,108)(H,92,116)(H,93,123)(H,94,117)(H,95,114)(H,96,115)(H,97,121)(H,98,122)(H,99,118)(H,100,120)(H,101,119)(H,109,110)(H,111,112)(H,125,126)(H2,89,90,128)/t43-,44+,53-,54-,55-,56-,57-,58-,59-,60-,61-,69-,70-,71-/m0/s1
Standard InChI Key: SMWDVQQKOSNRRS-LIDMWDOWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1839.08 | Molecular Weight (Monoisotopic): 1837.7691 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Qiu Y, Li X, He X, Pu J, Zhang J, Lu S.. (2020) Computational methods-guided design of modulators targeting protein-protein interactions (PPIs)., 207 [PMID:32871340] [10.1016/j.ejmech.2020.112764] |
Source(1):